Menu Back to DIA-Middle-East-Regulatory-Conference

Overview

This is the 12th DIA Middle East Regulatory Conference (MERC) in partnership with the Middle East Regulatory Network (MERN). The conference will bring together most authorities from the Middle East region and discuss the hot topics in the region, such as serialisation and life cycle management. Recent developments at country-level are also discussed. This conference is one of its kind and takes place biennially. It has grown rapidly over the past years and early registration is recommended.

Our Middle East Regulatory Conference programme committee, pulled together their thoughts on regulatory progress made in countries across the region. Examples include: Issue of fast track regulation in Egypt, and Update on pricing regulations in Lebanon. View Infographic

View the Global Forum articles from the 2013 MERC & 2015 MERC

 

Featured topics

The programme is under development and will be updated frequently. We recommend visiting the page for updates.

  • Updates from authorities in operating in the region
  • Facilitated regulatory pathways
  • Life cycle management
  • Safety Labelling updates
  • Pharmacovigilance in the Middle East
  • Who should attend?

    The conference offers the opportunity for key stakeholders active or interested in this diverse and changing region, including representatives from regulatory agencies, ministries of health, local and multi-national pharmaceutical companies, to meet to exchange views, discuss topics of interest and identify actions to increase patient access to new and improved medicines and therapies.

    Program Committee

    • Kerstin  Ahrendt-Soelter
      Kerstin Ahrendt-Soelter Senior Director Corporate
      Biotest AG, Germany
    • Donia   Al Bastaki
      Donia Al Bastaki Head of Registration Department, Pharmaceutical & Herbal Medicines Registration
      Ministry of Health, Drug and Food Control, Kuwait
    • Sarah  Al Maqseed
      Sarah Al Maqseed Registration and Release Superintendent
      Ministry of Health, Kuwait, Kuwait
    • Tamara  Al Rabi
      Tamara Al Rabi Head of Regulatory Affairs, Levant
      Pfizer, Jordan
    • Hassaan S  Alwohaibi
      Hassaan S Alwohaibi Executive Director of Regulatory Affairs Directorate
      Saudi Food and Drug Authority (SFDA), Saudi Arabia
    • Haitham  Alzuhair
      Haitham Alzuhair RA Director
      Janssen Pharmaceutical Companies of J&J, Saudi Arabia
    • Ihab  Attia
      Ihab Attia Regulatory Director
      Eli Lilly and Company, United Arab Emirates
    • Adele  Choueiry
      Adele Choueiry Head, Regulatory Affairs, Levant Region; Lebanon Regulatory Working Group Chair
      Novartis , Lebanon
    • Paul  Dearden
      Paul Dearden Senior Director, Global Regulatory Policy
      Biogen, United Kingdom
    • Greg  Jordinson, MSc
      Greg Jordinson, MSc Associate Director, Global Regulatory Affairs
      Janssen R&D, United Kingdom
    • Mounay Hussein Khafaja, PharmD, MSc
      Mounay Hussein Khafaja, PharmD, MSc Regulatory Affairs Director & Regulatory Center of Excellence, IRWG Group Chair
      Merck, Lebanon
    • Samia Gamal Seleem, PharmD, RAC
      Samia Gamal Seleem, PharmD, RAC Scientific & Regulatory Affairs Director
      Abbvie, Egypt
    • Marloes  van der Geer, MS
      Marloes van der Geer, MS Regulatory Affairs Scientist
      Qdossier, Netherlands
    • Nadine  Otin
      Nadine Otin President
      PHARMAREG International Consulting, France
    Load More

    Digital Learning Catalog

    DIA Learning: eLearning Soultions
    Download